0001628280-22-015035.txt : 20220520
0001628280-22-015035.hdr.sgml : 20220520
20220520161057
ACCESSION NUMBER: 0001628280-22-015035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220518
FILED AS OF DATE: 20220520
DATE AS OF CHANGE: 20220520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILNE GEORGE M JR
CENTRAL INDEX KEY: 0001179552
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 22947697
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4
1
wf-form4_165307739688602.xml
FORM 4
X0306
4
2022-05-18
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001179552
MILNE GEORGE M JR
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
1
0
0
0
Restricted Stock Unit
2022-05-18
4
A
0
8733
0
A
Common Shares
8733.0
8733
D
Stock Option (right to buy)
11.45
2022-05-18
4
A
0
14612
0
A
2032-05-18
Common Stock
14612.0
14612
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant.
The option vests in twelve equal monthly installments commencing on June 18, 2022.
/s/ George M. Milne, Jr., Ph.D.
2022-05-20